Latest Clinical trials biotechnology articles and news on biotech industry leaders, emerging biotech companies in Spain

WHO recommends an integrase inhibitor as preferred HIV treatment option in all populations

by Fundació Bancària 'la Caixa'

5 years ago
epidemic, HIV, OMS, inhibitor

The WHO Guideline Development Group decided to recomment dolutegravir as the preferred first-line and second-line treatment for all populations, in contrast with initial studies.

Nuestro gran reto es sacar al mercado un fármaco específico para la SOP y, ahora mismo, nos encontramos inmersos en la preparación de un proyecto europeo que nos permitiría realizar un ensayo clínico de fase II

by Fundació Sant Joan de Déu

5 years ago
anticonceptivos, ovario, poliquístico, SOP, fármaco

La Dra. Lourdes Ibáñez, endocrinóloga pediátrica del Hospital Sant Joan de Déu Barcelona, dirige desde hace más de 15 años el grupo de investigación de Endocrinología Metabólica del Institut...

Nueva estrategia combinada de inmunoterapia más eficaz para el tratamiento del linfoma

by CIMA - Centro de Investigación Médica Aplicada

5 years ago
inmunoterapia, linforma, sistema inmunitario

El trabajo del Cima y de la Clínica Universidad de Navarra descubre, además, nuevos mecanismos genéticos implicados en esta enfermedad

Collection and Management of Concomitant Medications in Clinical Trials

by Syntax for Science S.L

5 years ago
good practices, medications, food supplements, clinical trials, effects

On some occasions sponsors and investigators might challenge the need to collect concomitant medications during clinical trials. In this article, we briefly summarize the importance and the most exten...

ORYZON Announces End of Patient Recruitment for its Phase IIa trials in aggression with vafidemstat: REIMAGINE and REIMAGINE-AD

by Oryzon Genomics

5 years ago
ORYZON, trials, patient, REIMAGINE, REIMAGINE-AD, psychiatric disorders, Alzheimer

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announce...

OncoDNA adds the analysis of germinal DNA, a crucial marker in the management of ovarian, prostate, pancreas and triple-negative breast cancers

by OncoDNA

5 years ago
DNA, cancer, ovarian, prostate, pancreas, breast

OncoDNA adds the analysis of germinal DNA, a crucial marker in the management of ovarian, prostate, pancreas and triple-negative breast cancers

Comienza el primer ensayo clínico que utilizará directamente en pacientes la tecnología CRISPR de edición del genoma

by Revista Genética Médica

5 years ago
hereditaria, retina, Leber, genoma, ceguera

Se inicia el primer ensayo clínico que utilizará la tecnología CRISPR de edición del genoma directamente en pacientes. En el ensayo se probará un tratamiento destinado a corregir, en las propias ...

VHIO and Catalan Blood & Tissue Bank trial to assess novel T-cell therapy

by Vall d’Hebron

5 years ago
VHIO, Catalan Blood, Tissue Bank, T-cell therapy, ViroTCell

Officially announced today, VHIO and the Catalan Blood and Tissue Bank (Banc de Sang i Teixits – BST), in collaboration with the Hospital La Fe in Valencia and other Catalonia-based hospitals, have ...

New gene therapy for autosomal dominant retinitis pigmentosa

by DBGen Ocular Genomics

5 years ago
gene therapy, retinitis, drug, dystrophy

The United States Food and Drug Administration (FDA) has just approved the designation of the QR-1123 therapy by the Dutch company ProQR as a new investigational drug. This drug aims to treat a form o...

The manufacturing process for Strangvac, the new vaccine against equine strangles, is proceeding according to plan

by 3P Biopharmaceuticals

5 years ago
Praxis Pharmaceuticals, Strangvac, 3P Biopharmaceutical, vaccines, proteins

The biotechnology company Intervacc has together with 3P Biopharmaceuticals, the contracted manufacturer of Strangvac, finalized the production of the drug substances on a commercial scale in complian...

Demuestran la efectividad de un nuevo tratamiento para el cáncer de vejiga

by Agencia Sinc

5 years ago
fármaco, cáncer de vejiga, tabaquismo, proteína

Los resultados preliminares de un ensayo clínico liderado por el Instituto Hospital del Mar de Investigaciones Médicas y el Hospital del Mar muestran una buena respuesta a un fármaco en pacientes c...

IDIVAL patents a multivalent vaccine against listeriosis, tuberculosis and pneumonia

by Instituto de Investigación Marqués de Valdecilla

5 years ago
vaccine, listeriosis, tuberculosis, pneumonia, infections

After the last outbreak of listeriosis occurred in Spain, the bacterium Listeria monocytogenes, has established itself in Spain as one of the pathogens causing more virulent food infections.